View Clinical Trial (Medical Research Study)


Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial - NCT00789932-90095(Clinical Trial 252539)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Los Angeles
State:  
CA
Zip Code: 90095
Conditions: Autism Spectrum Disorder
Purpose: This study is designed to examine the efficacy of a cognitive behavioral therapy (CBT) program for treating core autism symptoms, social and emotional problems, and adaptive behavior deficits in children with autism spectrum disorders.
Study summary:
Criteria: Inclusion criteria: - 7 - 11 years of age - meet research criteria for a diagnosis of autism, Asperger Syndrome, or PDD-NOS - meet DSM-IV criteria for one of the following anxiety disorders: Separation Anxiety Disorder, Social Phobia, Obsessive-Compulsive Disorder - If taking medication, have maintained a stable dose for 1 month prior to baseline assessment Exclusion Criteria: - child has an IQ of less than 80 - begin taking new medication(s) or current medication dose changes either (1) less than 1 month prior to baseline assessment, or (2) during the study period - for any reason the child or parents appear unable to participate in the treatment program
Study is available at: UCLA
Los Angeles, CA 90095
United States

Primary Contact:
Jeffrey Wood, PhD
Email: jeffwood@ucla.edu
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.